The Influence of Prednisone on the Efficacy of Cabazitaxel in Men with Metastatic Castration-Resistant Prostate Cancer

Background: Cabazitaxel is a second-generation taxane that is approved for use with concomitant low dose daily prednisone in metastatic castration resistant prostate cancer (mCRPC) after docetaxel failure. Since the role of daily corticosteroids in improving cabazitaxel efficacy or ameliorating its...

Descripción completa

Detalles Bibliográficos
Autores principales: Buonerba, Carlo, Sonpavde, Guru, Vitrone, Francesca, Bosso, Davide, Puglia, Livio, Izzo, Michela, Iaccarino, Simona, Scafuri, Luca, Muratore, Margherita, Foschini, Francesca, Mucci, Brigitta, Tortora, Vincenzo, Pagliuca, Martina, Ribera, Dario, Riccio, Vittorio, Morra, Rocco, Mosca, Mirta, Cesarano, Nicola, Di Costanzo, Ileana, De Placido, Sabino, Di Lorenzo, Giuseppe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2017
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5604196/
https://www.ncbi.nlm.nih.gov/pubmed/28928853
http://dx.doi.org/10.7150/jca.20040

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5604196/
https://www.ncbi.nlm.nih.gov/pubmed/28928853
http://dx.doi.org/10.7150/jca.20040

Ejemplares similares